Letter to the Editor
We thank the authors for their comments on our methadone and buprenorphine article. Although the data presented by Ojanperä et al 1 is concerning, with methadone having the highest fatal toxicity index, information is not available on the population that these events occurred in (ie, neonates, adults, methadone acquired by illegal means, adults in methadone clinic). Therefore, the results are not generalizable to the neonatal and pregnant population.
We agree that the literature has shown that buprenorphine significantly improved specific outcomes as compared with methadone-specifically, development of neonatal absitinece syndrome (NAS), duration of NAS, infant hospital stay, total amount of morphine used to treat NAS, and gestational age at delivery. However, before ruling that buprenorphine should be first-line therapy before methadone, it is important to take into consideration some patient-specific factors. For example, if the patient, prior to pregnancy, is stable on methadone, the American College of Obstetricians and Gynecologists (ACOG) does not recommend transitioning to buprenorphine because of the significant risk of precipitated withdrawal. 2 Another important factor to take into consideration is the initial higher dissatisfaction association with buprenorphine, which is likely a result of its longer induction phase. Because of this longer induction phase, some patients may discontinue therapy because of their inability to control withdrawal symptoms as quickly as with methadone. Another key point to keep in mind is the risk of abuse and diversion, which may be more likely with buprenorphine in some patients. This in turn leads to a higher failure rate with buprenorphine. Therefore, some patients who cannot handle self-administration may be better served with daily supervision of administration with methadone. Finally, the patient's preference and previous experience with both methadone and buprenorphine need to be taken into account before starting a patient on either of these 2 agents.
Based on these factors, we recommend that buprenorphine be considered a potential equivalent to methadone for opioid dependence in pregnancy and that management should be individualized for each patient specifically.
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